物质信息

ID:1824214

名称和标识
IUPAC标准名
(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid
IUPAC传统名
pravastatin
别名
pravastatin(+)-(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(S)-2-methylbutyryl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoic acidpravastatin acid
国际非专利药品(INN)
pravastatinpravastatinapravastatinepravastatinum
数据登录号
PubChem CID
KEGG ID
KNApSAcK数据库
LINCS数据库
PubMed文献链接
Reaxys Registry
ACToR数据库
BKMS React数据库
BRENDA Ligand数据库
CompTox数据库
SureChEMBL数据库
UniProt数据库
HMDB数据库
维基百科标题
DrugBank ID
Drug Central Database
KEGG DRUG Database
PubChem SID
化合物性质
暂无数据
点击上传数据
描述信息
A carboxylic ester resulting from the formal condensation of (S)-2-methylbutyric acid with the hydroxy group adjacent to the ring junction of (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6,8-dihydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid. Derived from microbial transformation of mevastatin, pravastatin is a reversible inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA). The sodium salt is used for lowering cholesterol and preventing cardiovascular disease. It is one of the lower potency statins, but has the advantage of fewer side effects compared with lovastatin and simvastatin.
分子图谱
暂无数据
点击上传数据
参考文献
暂无数据
点击上传数据